Close

BLTI Financial Facts

Net revenue: 13.23M
Sales and marketing: 4.26M
See Full Income Statement

Deferred revenue, current portion: 3.04M
Total stockholders' equity (deficit): 26.06M
See Full Balance Sheet

Biolase Technology (BLTI) Earnings

  |   Expand Research on BLTI
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -25.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -0.3% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/9/12 Q112 -$0.03-$0.02 -$0.01$12.3M$10.51M N/A Details
3/8/12 Q411 -$0.04-$0.02 -$0.02$13.14M$13.1M = Details
11/7/11 Q311 -$0.01-$0.02 +$0.01$13.1M$13.48M N/A Details
8/10/11 Q211 $0.00$0.00 $0.00$12.08M$12.01M N/A Details
5/9/11 Q111 $0.00$0.02 -$0.02$10.6M$9.56M Details
11/2/10 Q310 -$0.09$0.09 -$0.18N/AN/A N/A Details